EREllen Luken Risemberg

Ellen Luken Risemberg

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ellen Luken Risemberg has a total of 41 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Systems genetics analysis reveals immune mediators of coronavirus disease severity in mice

    by Ellen L Risemberg, Sarah R Leist, Alexandra Schäfer, Kalika D Kamat, Timothy A Bell, Pablo Hock, Kara L Jensen, Colton L Linnertz, Darla R Miller, Ginger D Shaw, et al.

    Severe disease following infection with SARS-CoV or SARS-CoV-2 is driven in part by genetically regulated immune responses that promote lung injury. To study genetic mechanisms of immune-mediated coronavirus pathogenesis, we screened the Collaborative Cross (CC) panel for Mus musculus strains that are phenotypically divergent with respect to coronavirus susceptibility. We identified CC006/TauUnc and CC044/UncJ as susceptible and resistant, respectively, and crossed them in an intercross to produce a genetic mapping population. Previously, we mapped genetic loci associated with disease severity, including HrS43, which is both conserved across viruses and between mouse and human. Here, we incorporate immune cell data from flow cytometry and perform a systems genetics analysis to resolve immune pathways linking host genetic loci to disease outcomes. We identify: (1) immune predictors of disease severity, as revealed by Bayesian variable selection; (2) extensive genetic regulation of the immune system at homeostasis and in response to infection, as revealed by infection-stratified and combined genotype-by-treatment (GxT) QTL mapping; and (3) candidate causal pathways linking genetic loci, immune responses, and disease severity, as revealed by context-dependent Bayesian mediation analysis. Our analysis reveals distinct patterns of virus specificity across biological layers: immune effects on disease severity appear largely consistent across viruses; genetic architecture is both shared and virus-specific; and mediating immune traits are in most cases virus-dependent. Notably, HrS43 appears to influence disease severity through distinct immune mediators in SARS-CoV versus SARS-CoV-2, demonstrating that conserved genetic susceptibility can drive virus-specific immunopathology with translational relevance across species.

  • Open Access

    Cross-coronavirus host susceptibility loci influence disease severity through immune mediators

    by Ellen L. Risemberg, Sarah R. Leist, Alexandra Schäfer, Kalika D. Kamat, Timothy A. Bell, Pablo Hock, Kara L. Jensen, Colton L. Linnertz, Darla R. Miller, Ginger D. Shaw, et al.

    Severe disease following infection with SARS-CoV or SARS-CoV-2 is driven in part by genetically regulated immune responses that promote lung injury. Previously, we showed that genetic risk for severe disease is conserved across viruses and between mouse and human, identifying the HrS43 locus as a shared determinant of severity. Here, to resolve immune pathways linking host loci to disease outcomes, we apply an integrative statistical framework combining Bayesian identification of predictive immune traits with QTL mapping and mediation analysis across infection conditions. This approach identifies immune predictors of disease severity across both viruses, reveals extensive genetic control of the immune system at homeostasis and during infection, and supports locus-specific causal mechanisms of immunopathology. Notably, HrS43 appears to influence disease severity through distinct immune mediators in SARS-CoV versus SARS-CoV-2, demonstrating that conserved genetic susceptibility can drive virus-specific immunopathology with translational relevance across species.

  • A mutation in Themis contributes to anaphylaxis severity following oral peanut challenge in CC027 mice

    by Ellen L. Risemberg, Johanna M. Smeekens, Marta C. Cruz Cisneros, Brea K. Hampton, Pablo Hock, Colton L. Linnertz, Darla R. Miller, Kelly Orgel, Ginger D. Shaw, Fernando Pardo Manuel de Villena, et al.


  • Open Access

    Sarbecovirus disease susceptibility is conserved across viral and host models

    by Sarah R. Leist, Alexandra Schaefer, Ellen Luken Risemberg, Timothy A. Bell, Pablo Hock, Mark R. Zweigart, Colton L. Linnertz, Darla R. Miller, Ginger D. Shaw, Fernando Pardo Manuel de Villena, et al.

    Coronaviruses have caused three severe epidemics since the start of the 21 st century: SARS, MERS and COVID-19. The severity of the ongoing COVID-19 pandemic and increasing likelihood of future coronavirus outbreaks motivates greater understanding of factors leading to severe coronavirus disease. We screened ten strains from the Collaborative Cross mouse genetic reference panel and identified strains CC006/TauUnc (CC006) and CC044/Unc (CC044) as coronavirus-susceptible and resistant, respectively, as indicated by variable weight loss and lung congestion scores four days post-infection. We generated a genetic mapping population of 755 CC006xCC044 F2 mice and exposed the mice to one of three genetically distinct mouse-adapted coronaviruses: clade 1a SARS-CoV MA15 (n=391), clade 1b SARS-CoV-2 MA10 (n=274), and clade 2 HKU3-CoV MA (n=90). Quantitative trait loci (QTL) mapping in SARS-CoV- and SARS-CoV-2-infected F2 mice identified genetic loci associated with disease severity. Specifically, we identified seven loci associated with variation in outcome following infection with either virus, including one, HrS45 , that is present in both groups. Three of these QTL, including HrS45 , were also associated with HKU3-CoV MA outcome. HrS45 overlaps with a QTL previously reported by our lab that is associated with SARS-CoV outcome in CC011xCC074 F2 mice and is also syntenic with a human chromosomal region associated with severe COVID-19 outcomes in humans GWAS. The results reported here provide: (a) additional support for the involvement of this locus in SARS-CoV MA15 infection, (b) the first conclusive evidence that this locus is associated with susceptibility across the Sarbecovirus subgenus, and (c) demonstration of the relevance of mouse models in the study of coronavirus disease susceptibility in humans.

  • Open Access

    A mutation in Themis contributes to peanut-induced oral anaphylaxis in CC027 mice

    by Ellen L. Risemberg, Johanna M. Smeekens, Marta C. Cruz Cisneros, Brea K. Hampton, Pablo Hock, Colton L. Linnertz, Darla R. Miller, Kelly Orgel, Ginger D. Shaw, Fernando Pardo Manuel de Villena, et al.

    Background: The development of peanut allergy is due to a combination of genetic and environmental factors, although specific genes have proven difficult to identify. Previously, we reported that peanut- sensitized CC027/GeniUnc (CC027) mice develop anaphylaxis upon oral challenge to peanut, unlike C3H/HeJ (C3H) mice. Objective: To determine the genetic basis of orally-induced anaphylaxis to peanut in CC027 mice. Methods: A genetic mapping population between CC027 and C3H mice was designed to identify the genetic factors that drive oral anaphylaxis. A total of 356 CC027xC3H backcrossed mice were generated, sensitized to peanut, then challenged to peanut by oral gavage. Anaphylaxis and peanut-specific IgE were quantified for all mice. T-cell phenotyping was conducted on CC027 and five additional CC strains. Results: Anaphylaxis to peanut was absent in 77% of backcrossed mice, with 19% showing moderate anaphylaxis, and 4% having severe anaphylaxis. A total of eight genetic loci were associated with variation in response to peanut challenge, six associated with anaphylaxis (temperature decrease) and two associated with peanut-specific IgE levels. There were two major loci that impacted multiple aspects of the severity of acute anaphylaxis, at which the CC027 allele was associated with worse outcome. At one of these loci, CC027 has a private genetic variant in the Themis (thymocyte-expressed molecule involved in selection) gene. Consistent with Themis ’ described functions, we found that CC027 have more immature T cells with fewer CD8+, CD4+, and CD4+CD25+CD127- regulatory T cells. Conclusion: Our results demonstrate a key role for Themis in the orally-reactive CC027 mouse model of peanut allergy.